Page last updated: 2024-09-05

dofequidar and Neoplasms

dofequidar has been researched along with Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Augustine, AM; Baranowska-Kortylewicz, J; Kortylewicz, ZP; McGarry, J; Nearman, J	1
Bonneterre, J; Bonneterre, ME; Degardin, M; Diéras, V; Fumoleau, P; Lacombe, D; Laurence, V; Marreaud, S; Pierga, JY	1
Ahmad, K	1
Naito, M; Nakanishi, O; Tsuruo, T	1
Turuo, T	1

Reviews

2 review(s) available for dofequidar and Neoplasms

Article	Year
[Overcoming of multidrug resistance by a newly synthesized quinoline compound, MS-209]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:5 Topics: Animals; Antineoplastic Agents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mice; Neoplasms; Quinolines; Tumor Cells, Cultured	1997
[Targeted immunotherapy for malignant tumors]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1999, Volume: 40, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Caspases; Drug Resistance, Neoplasm; Humans; Immunotoxins; Neoplasms; Quinolines; Tumor Cells, Cultured	1999

Trials

1 trial(s) available for dofequidar and Neoplasms

Article	Year
Phase I combining a P-glycoprotein inhibitor, MS209, in combination with docetaxel in patients with advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Sep-01, Volume: 11, Issue:17 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Prospective Studies; Quinolines; Taxoids; Treatment Outcome	2005

Article

Year

Phase I combining a P-glycoprotein inhibitor, MS209, in combination with docetaxel in patients with advanced malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Sep-01, Volume: 11, Issue:17

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Prospective Studies; Quinolines; Taxoids; Treatment Outcome

2005

Other Studies

2 other study(ies) available for dofequidar and Neoplasms

Article	Year
Radioiodinated agents for imaging multidrug resistant tumors. Medicinal chemistry (Shariqah (United Arab Emirates)), 2009, Volume: 5, Issue:2 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Hydrophobic and Hydrophilic Interactions; Iodine Radioisotopes; Mice; Mice, Nude; Molecular Structure; Neoplasms; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Temperature; Time Factors; Tissue Distribution; Verapamil	2009
Inhibitor of P-glycoprotein increases chemosensitivity. The Lancet. Oncology, 2007, Volume: 8, Issue:2 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Humans; Neoplasms; Quinolines	2007

Article

Year

Radioiodinated agents for imaging multidrug resistant tumors.

Medicinal chemistry (Shariqah (United Arab Emirates)), 2009, Volume: 5, Issue:2

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Hydrophobic and Hydrophilic Interactions; Iodine Radioisotopes; Mice; Mice, Nude; Molecular Structure; Neoplasms; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Temperature; Time Factors; Tissue Distribution; Verapamil

2009

Inhibitor of P-glycoprotein increases chemosensitivity.

The Lancet. Oncology, 2007, Volume: 8, Issue:2

Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Humans; Neoplasms; Quinolines

2007